Registration for Covid-19 vaccination for 18 to 44 years age group began - Direct Link: selfregistration.cowin.gov.in

I got it on the very first day itself. I was one of the unfortunate who had to stand in queue waiting outside hospital while Yogi was inaugurating the drive inside the hospital. That time I was able to get appt very easily, I was checking for the appt every hour on Apr 30th and initially booked one at a pvt hospital which was later cancelled and then it started showing one at a govt hospital.
But now looking at the situation I doubt if I will be get appt for my second dose in May end. All the time it shows all booked.

Dimers Beware! This SMS Claiming Free COVID-19 Vaccine Registration in India is Fake

Please refer this thread….
https://www.desidime.com/discussions/dimers-bew...

Odisha govt to provide vaccines to pvt hospitals to inoculate people in 18-44 age group

The Odisha government Thursday said it will provide private hospitals with COVID-19 vaccine to inoculate people in the 18-44 year age group and they will charge Rs 100 per beneficiary. Additional Chief Secretary (ACS), Health and Family Welfare, PK Mohapatra said the state government has decided to rope in the private hospitals, which were conducting vaccination till 30 April , for inoculation of the 18-44 age group people, so that more number of people will be covered. The state government will provide private hospitals with the vaccine and they will charge Rs 100 per beneficiary, he said.

Any update in Bangalore as I know only Apollo hospital in sheshadripuram has started for 18+ , and no slots are available checking since 4 days

Mumbai To Get Drive-In Vaccination Centres In Every Zone Within 24 Hours.

Mumbai will have more drive-in vaccination centres, maybe as soon as within 24 hours. That is the deadline given by the city’s civic body to its officials, who were told to have it ready in each administrative zone. The centres will cater to senior citizens and specially-abled people. The civic body has decided to keep the blueprint ready even though the state, like many others, is struggling with limited supply of the vaccine.

Drive-in vaccination centres will be set up in big open grounds — such as the Andheri Sports Club ground, Cooperage ground, Shivaji Stadium, Oval Maidan, Brabourne stadium, MIG ground, MCA ground, Reliance JIO garden or even the Wankhede stadium, the Brihanmumbai Corporation

Adequate and proper temporary shelter shall be provided for in the vaccination area to accommodate vaccination staff, arrangement for patients of AEFI, ambulance etc, the civic body has said.

Maharashtra got its first drive-in vaccination centre this week at Dadar. The success of the project pushed the civic body to adopt it for the country’s financial capital.

The centre has the capacity vaccinate nearly 5,000 people in a day with minimum risk of infection that would have been present in crowded places and long queues.

US supplies vaccine components enough to make 20 million Covishield doses to India.

The US on Wednesday said the vaccine components it has supplied to India this week will enable the manufacturing of two crore doses of the Covishield vaccine even as the sixth shipment of American medical aid arrived as part of the Biden administration’s assistance to the country’s response to a rising number of COVID-19 cases.

The United States also sent a separate shipment of over 81,000 vials of Remdesivir injections that was delivered in Mumbai.

Month-long Lockdown, Pop-up Hospitals, Vaccine: Dr Fauci on India’s Covid Conundrum.

India needs to pull together – as a united nation – bereft of political divisiveness to beat the common enemy which is the virus, said Dr Fauci.

Dr Fauci: Well, the thing that stands out, it has the dynamics, is really somewhat similar to the extraordinarily large wave that we had in the United States. At the end of the fall in the beginning of the winter where we were seeing 300,000 cases per day, and we were up at around 3,000 and sometimes as high and as close to 4,000 deaths per day. So there is a similarity there as I’ve mentioned when I was asked by several members of the Indian press, what my recommendation would be and what I thought would be going on.

I think it’s clear that you have to take the step of shutting down most of the country, particularly the involved areas and I don’t mean shutting down for six months, you don’t need to do that. You just need to break the chain of transmission, and one can do that by shutting down to the extent possible for two, three weeks, four weeks, and then as soon as the cases start coming down and you vaccinate more people, then you can get ahead of the trajectory of the outbreak because obviously, you’ve got to get as many people vaccinated as you possibly can. And when you do that, we’ve got to do public health measures.

The other thing that, at least from my viewpoint, looking at India from a distance, what we’re seeing on TV and in the printed press, is that there’s a dire need for hospital beds, people are not able to get a hospital bed. So the United States has responded, both with oxygen cylinders as well as oxygen generators, and PPE etc.

In so many respects, India has helped out other countries, when they’ve had difficulties, so I think as part of solidarity with India, we really need to show that we are really very concerned. One of the things that I thought that you might be able to do as you recall when the Chinese had their big surge over a year ago, they very rapidly put up hospitals, almost like field hospitals for the military. In the United States, our National Guard has been very helpful, for example, in the distribution of vaccines. If you can mobilise the Indian military to help out and maybe put up field hospitals, the way you would do for example, during armed conflict, that could temporarily alleviate the shortage of hospital beds.

The last time India went into a nationwide lockdown, we are still reeling under the economic repercussions.

I think it’s very clear from experiences that we’ve now had throughout the world, in these terrible 16 months that we’ve gone through that the economy is going to suffer badly if you don’t control the outbreak. So when you try and balance it, preserving the economy versus keeping the outbreak going, the best thing to do is to shut down the outbreak. When you close for a few weeks, the economy will recover. The economy is going to recover without a doubt. Look at what’s happened in the United States to the economy, it’s recovering very nicely. So I would think that if you’re talking about shutting down for a prolonged period of time, that’s a different story. But if you’re shutting down just long enough to break the chain of transmission, in the long run, it will be beneficial to the economy, as opposed to it being detrimental.

Two things are different this time around – a lot more younger people are getting affected, and a lot more people are asking for oxygen, having breathing issues. This is not something we noticed in the first wave.

Well, it appears that there are two types of variants now, in India, at least. One is the B117 which is the UK variant, which seems to be concentrating in New Delhi. And then there’s the 617, which seems to be more concentrating in Maharashtra. Now, that being the case, both of those have an increased capability of transmitting better and more efficiently than the original Wuhan strain from over a year ago that spread throughout the world. So, since it has a better capability of transmitting, you would expect to see all kinds of people young and old, getting infected more. The fact that people seem to be requiring oxygen more frequently, is entirely conceivable and there are data suggesting that this virus may be a bit more virulent, or a bit more dangerous, in the sense of making people more seriously ill, than the original virus. Both of those things could explain both younger people getting infected because the more efficient a virus spreads, the more people that can get infected, but also the requirement for oxygen very well may reflect the fact that it might be a bit more pathogenic.

What can India do to expedite the vaccination process and I’m looking for examples of things to learn from the US experience where I believe you’ve vaccinated more than 200 million people.

Well, there are two parts of the vaccination programme, and it may be that India right now is not in a position to have both of those going at the same time. One is to have an adequate supply of vaccine coming in at a rapid rate as you probably know, the United States contracted with multiple companies, particularly the two major mRNA companies as well as J&J. We contracted for a total of 600 million doses and each month there was a very good flow or cadence of vaccines coming in. That’s the first thing, the second thing was when President Joe Biden became president, he immediately instituted a very efficient way of implementing the delivery of vaccines into people’s arms. We did community vaccine centres, federally qualified health centres, pharmacies, mobile units. We got vaccinated as volunteers who are physicians and nurses who came out of retirement. We got our National Guard to help out. So it was a very, very aggressive – in a positive sense – effort to get the vaccine that we have into the arms of people. However, you can’t do that unless you have a steady supply. And so it seems that is what India has to do. Because remember, prior to this, India was the largest vaccine producing country in the world. So you’ve got to now take your own resources, make vaccine yourself. I know there’s a supply shortage, but try and get as many supplies as possible to rev up your own capability, and then try and get it from other countries.

Yesterday, the decision was taken by the US to waive off patent rights for many of the pharma companies manufacturing vaccines. What do you think of that decision? Will that help developing countries like India?

It will, but it won’t be an immediate fix because if companies transfer and don’t get any patent restrictions and are allowed to develop the technology to develop an mRNA vaccine, let’s say in New Delhi and Mumbai or wherever. The fact is, that’s going to take a while to get that up and running. So that’s a good solution intermediately and in the long range, but it doesn’t solve the problem that India has today and tomorrow or the next day. What you need now is for the vaccines to put directly into someone’s arm. You will need, in a year or in six months, the capability of manufacturing by technology transfer, but that’s going to take several months to a year to get running.

Have you or the CDC or any other institute had a chance to genome sequence or study the new variants in further detail?

Literally, as I’m speaking to you within the next few days to a week, we’ll be able to know what the capability of the currently-used vaccines is and to what degree they protect against the 617 variant.

So, you’re saying to deal with this current wave, more than vaccines, it is about having field hospitals, increasing bed capacity, making oxygen available. What would your prescription be to the Government of India if they were to ask for your advice?

I think you have to look at it as an immediate, an intermediate and a longer range. Right now, immediately, you have people dying, you have people needing hospitalisation. You’ve got to get them oxygen, drugs, personal protective equipment, a variety of things to save their lives. You’ve got to get hospital beds now, you can’t have people out in the street in taxi cabs getting oxygen, the way we see on the international TV, media, you have to correct that problem right now. Then there’s the intermediate, how do we get more vaccines so that we can prevent people from falling sick three weeks or a month from now. That means you got to get vaccines that are already produced. Then, in the longer range, you’ve got to be able to get the transfer of the right vaccine technology so that over the next six months to a year, you can prevent subsequent waves from coming in. So I look at it as three phases. Today, a few weeks to a month from now and many months to a year from now.

Is there a fear of a third wave and a fourth wave, because it seems like with each new wave, the intensity of the disease, its ability to spread and to cause long term damage is that much more.

We’re experiencing that when you get a good vaccine, like the ones we’re vaccinating with, you get a higher tide of neutralising antibodies that not only protect against the original virus but there is a spill-over effect – not 100 per cent – but enough to protect people from getting a serious disease from the variants. So what I believe will happen is that if India now gets as many people vaccinated as they possibly can with their large population of 1.4 billion people now, even when we get new variants, the vaccination that you do now will very likely cushion or buffer the effect of a new variant. It may come, but I don’t think you’re going to get a very serious disease if you get almost everybody vaccinated because even though the vaccine may not be specific against the variant, it will have some effect against the variant.

There seems to be a lot of emphasis on Remdesivir and also steroids like Dexamethasone. I know there isn’t a standard prescription for this but what would your advice be as to when to go in for these medicines?

Right now, you want specific drugs against the virus to begin very early on, when people get symptoms to prevent them from going to the hospital. Once they’re in the hospital and require mechanical ventilation or high flow oxygen, that’s a different type of pathogenesis, you’ve got to suppress the inflammation, and the aberrant immune response. That’s the reason why Dexamethasone works so well. And next semester will embarrass cinnamon and other things that suppress inflammation. So you have to have two poles of the treatment, one early on to prevent people from going to the hospital and then once they’re there, and they get seriously ill, you’ve got to suppress that apparent inflammation.

Dr Fauci, you’ve led an entire nation through a very turbulent time of Covid-19. You were a voice of reassurance in your daily briefings. What has been the biggest learning for you that you would like to share with readers in India?

I think you can learn from the difficulties that other countries have had. In the United States, when we went through a very difficult time and we’re still not out of it completely, one of the things you’ve got to do is pull together as a united nation. You can’t have divisiveness among you, the common enemy is the virus. So you’ve got to put aside all political disagreements, all ideological differences and focus on one thing, like a laser beam. The enemy is the virus. You’ve got to fight the virus together, particularly when you have a big, diverse country like the United States, and a big diverse country like India, you’ve got to put all of your resources and focus just on the virus, that’s the lesson that I’ve learned.

Sputnik Light, Russia’s single-dose Covid vaccine will be produced in India

https://www.wionews.com/india-news/sputnik-ligh...

Vu

Vaccination drive for 18-44 age group in 11 more Uttar Pradesh districts.

The Uttar Pradesh government has decided to scale up the Covid-19 vaccination programme for the 18-44 age group. “The vaccination for people above 18 years of age will now be conducted in all the 17 nagar nigams as well as Gautam Budh Nagar from next week,” said Chief Minister Yogi Adityanath here on Thursday.

The campaign began in seven districts on May 1. The criteria of selection included districts having more than 9,000 active cases namely — Lucknow, Kanpur, Prayagraj, Varanasi, Gorakhpur, Meerut, and Bareilly.

The new additions will be "Aligarh, Agra, Ghaziabad, Jhansi, Moradabad, Saharanpur, Firozabad, Mathura, Ayodhya, Shahjahanpur and Gautam Budh Nagar.*

At a meeting to review the progress of the vaccination programme in the state convened by the CM, health officials revealed that vaccine wastage had been brought to 0.5% which is negligible in a way. Insiders revealed that the wastage was in fact incidental while flaws in planning and micro-planning had been eliminated. The officials also said that so far, 68, 536 persons in the age group of 18-44 have been vaccinated.

Later, health officials urged people to come forward to take Covid-19 vaccine as it was the other important pillar of Covid-19 containment besides prevention.

UP to get 1cr doses of vaccine next week: Health officials claimed that to ensure the availability of adequate doses of the vaccine in Uttar Pradesh, the state government has ordered to procure 50-50 lakh doses of Covishield and Covaxin each, from the manufacturing companies. Stating that the consignment was expected for delivery next week, officials assured that there was no dearth of the stocks even today.

Earlier, the Yogi government had floated a short term global tender for 40 million doses of vaccines.

Centre approves anti-Covid drug developed by DRDO for emergency use.

The Centre has approved an anti-Covid drug developed by DRDO for emergency use, the Union Defence Ministry Saturday said. The drug, 2-deoxy-D-glucose (2-DG), has been developed in collaboration with Dr Reddy’s Laboratories.

The Drugs Controller General of India (DCGI) has approved the emergency use of drug 2-deoxy-D-glucose (2-DG) as an adjunct therapy in moderate to severe Covid-19 patients.

The Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), has developed the drug, in collaboration with Dr Reddy’s Laboratories, Hyderabad.

“Clinical trial results have shown that this molecule helps in faster recovery of hospitalized patients and reduces supplemental oxygen dependence. Being a generic molecule and analogue of glucose, it can be easily produced and made available in plenty. Higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in Covid patients,” DRDO said in an official statement on Saturday.

In April 2020, during the first wave of Covid-19, INMAS-DRDO scientists had conducted laboratory experiments with the help of Centre for Cellular and Molecular Biology (CCMB), Hyderabad and found that this molecule works effectively against SARS-CoV-2 virus and inhibits the viral growth.

Based on these results, DCGI Central Drugs Standard Control Organization (CDSCO) gave permission for phase-II clinical trial of 2-DG in Covid-19 patients in May 2020.

In phase-II trials (including dose ranging) conducted during May to October 2020, the drug was found to be safe in Covid-19 patients, and showed significant improvement in their recovery. Phase-IIa was conducted in 6 hospitals and phase-IIb (dose ranging) clinical trial was conducted at 11 hospitals all over the country.

“In efficacy trends, the patients treated with 2-DG showed faster symptomatic cure than Standard of Care (SoC) on various endpoints. The drug comes in powder form in sachet, which is taken orally by dissolving it in water. It accumulates in the virus-infected cells and prevents virus growth by stopping viral synthesis and energy production,” the statement added.

Based on successful results, DCGI further permitted the phase-III clinical trials in November 2020. The Phase-III clinical trial was conducted on 220 patients during December 2020 to March 2021 at 27 Covid-1 hospitals situated in states of Delhi, UP, West Bengal, Gujrat, Rajasthan, Maharashtra, Andhra Pradesh, Telangana, Karnataka and Tamil Nadu.

In 2-DG arm, significantly higher proportion of patients improved symptomatically and became free from supplemental oxygen dependence (42% vs 31%) by day-3 in comparison to SOC, indicating an early relief from oxygen therapy/dependence, the statement said

https://www.desidime.com/discussions/centre-app...

Any idea how to get slots? Seems like its 100 times harder than tatkal train booking right now.

Telangana Halts First Dose Till May 12, Focuses on 2nd Dose Amid Supply Crunch.

Amid shortage of Covi-19 vaccines, Telangana health officials have stopped registration for first dose of inoculation and have, instead, intensified the drive to give jabs to people awaiting their second dose. The government said that those people who have taken their first dose can go to any government vaccination centre for the second round on 10, 11 or 12 May.

Vaccination centres are witnessing huge rush of people across the state as fresh coronavirus cases continue to mount at an exponential rate. Amid the intensified vaccination drive, the health officials are more focused on breaking the chain of coronavirus transmission Chief Secretary Somesh Kumar, health secretary S Rizvi and other officials visited Golconda Hospital on Saturday where they inspected the preparedness of the healthcare services.

Telangana on Saturday reported 5,186 fresh COVID-19 cases, taking the tally to over 4.92 lakh while the toll rose to 2,704 with 38 more casualties. Greater Hyderabad Municipal Corporation (GHMC) accounted for the most number of cases with 904, followed by Rangareddy (399) and Medchal Malkajgiri (366), a government bulletin said.

Dr Reddy’s may also distribute Sputnik Light

Sputniklite, a single-shot Russian Covid-19 vaccine approved for use in Russia on Thursday, will be distributed by Dr. Reddies Labs of India.
A sales partnership with the Russian Direct Investment Fund (RDIF) for Sputnik V has already been entered into.

“Sputnik Light will also be distributed by Dr Reddy’s Laboratories in India, but only after the necessary approvals have been obtained,” a source told the TOI. Dr. Lady’s officials declined to comment on the development as the company is in a silent period prior to next week’s quarterly earnings announcement.

According to experts, single-shot Sputnikrite can reduce logistical challenges and could be a major boost to India’s vaccination drive, which is significantly deficient in vaccines even on a second vaccination.

Sputniklite showed 79.4% efficacy 28 days after administration, as opposed to the 92% efficacy demonstrated by double-dose Sputnik, and the RDIF reported that the price was less than $ 10 per dose. Stated.

Meanwhile, the 1.5-rack initial dose of Sputnik V, which arrived in Hyderabad on May 1, is being tested at the Central Pharmaceutical Research Institute in Kasauli and is expected to be ready for deployment in mid-May.

Dr. Reddy’s uses the first shipment to test the cold chain in both rural and urban areas to ensure that the supply chain is functioning properly. The company has not yet announced the price of Sputnik V. Sputnik V has a worldwide flat price of $ 10 per dose.

I think they did everything in a hurry.

Some of us within 18-44 yrs managed to get the first jab but there’s absolutely no clarify whether and when we’ll get the second dose as even walk in isn’t allowed even for second dose

If we miss the second dose then there’s absolutely no point in getting vaccinated

Not true, please get vaccinated and don’t spread rumours. You can get 2nd dose laster as per availability. Getting 2nd dose will increase the protection. If you don’t get it on time then also not a big issue. It’s not like it is completely necessary and 1st dose is useless.

Please get vaccinated if possible, also don’t believe on rumors.

Karnataka to start vaccinations for 18-44 age groups from May 10.

Karnataka has announced vaccination for people between the ages 18 to 44 from May 10 after it was delayed due to lack of supplies by the vaccine manufacturers.

In Bengaluru, the vaccinations will be administered at KC, Jayanagar, CV Raman Gen. Hospitals , Govt Medical Colleges, ESI Hospitals, NIMHANS, other districts. Shots will be given to only those whose slots are scheduled on the CoWin portal.

One of the most worthless app. I have been trying to get a schedule since last 5 days in Pune but still not succeeded. Atmost I reach the schedule selection page with Captcha which never ever accepts it or always says invalid. And after few seconds, slots are full.

Dimers of Karnataka vaccine slots opened for 18-44 age book ASAP guys

Any script to get vaccine update or auto book?

Any help for Mumbai?

Odisha to vaccinate 18-44 age group 1st in 5 cities with high Covid TPR

The vaccination for 18-45 years age group in Odisha will first begin in five urban centres of Bhubaneswar, Cuttack, Rourkela, Sambalpur and Berhampur that have reported high Covid-19 test positivity rate (TPR). The additional chief secretary of health, PK Mohapatra, briefed district collectors, municipal commissioners and chief district medical officers among others in this regard underlining that prioritisation was being done due to low supply of vaccines. One lakh doses of Covishield was received by the state on Saturday.

Till Saturday, Odisha has administered 6,148,532 doses of Covid vaccine including 51 lakh doses to those older than 45 years and over 10 lakh to healthcare and frontline workers.

Residents in the 18-44 years age group are being vaccinated at government centres between 8 AM to 1 PM at Bhubaneswar while those above 45 years have been slotted between 3 PM and 6 PM.

When the vaccine supply improves, this group will be vaccinated in other districts of the state too, Mohapatra said.

Odisha has decided to vaccinate over 1.93 crore people in the age group of 18-44 years free of cost with a proposed expenditure of over ₹2,000 crores. Private hospitals can take ₹100 per dose as service charge but it will be completely free at govt vaccination centres.

To speed up the vaccination drive and decongest existing inoculation centres, the state government on Friday started ‘Drive in Vaccination’ in Bhubaneswar where 400 people in the age group of 45+ years were jabbed at the parking area of a mall. The government also plans to start vaccination in stadiums to ensure social distancing, maintaining which is currently a challenge at the existing vaccination centres.

I recently booked appointment for covishield 2nd dose for my parents on 12th may.
today received msg from cowin that booking cancelled because of vaccine unavailability..
kitna ghatiya management hai inka..gaali dene ka man kar raha hai..

did anyone of you, below 45, got slots/vaccine in North Delhi?
I have been trying daily since registration opened, but no slots.

• None of the slot notifying apps helped booking vaccine slot for 18+ *
  Today I booked vaccine slots for me and my family members. Wanted to share a few pointers so that it will help those booking:

• None of the apps notified the availability. I had registered with paytm, healthify and a few telegram bots. Not even one of them showed notification when slots opened.
• Slots open at different times in different centers and also at different times at different booths in same center.
• We can not know when a center puts slots for booking. Its completely localised. Maybe hospital people decide.
• For me it was sheer luck and there were slots when I checked cowin. There were 100 slots but in 1-2 minutes slots are gone.
• Slots appear a bit late if you check cowin without logging in. Once u are logged in to schedule appointment the slots were free but in the website without logging, the slots were yet to be put up for booking (It was showing NA).
• With a system like this and only around 100- 200 per day/per hospital for 18+, at least in the place I live it will be difficult to cover all!!
  Good luck!

Jaroori thread aagayi… Koi to ab bulayega mere modi ko…

Jab Vaccine itni h hi ni , to puri population ko ek sath lagane ka idea ekdum Ghatiya h. Vaccine lagane k chakkar m adhe log to Corona le aate h sath me.

I have booked slots several times over the last 2 weeks for my mother (2nd dose Covaxin) but had to return empty handed everytime. Now no booking allowed for almost a week. As is the norm for this govt. many a slip between planning and execution. Reactive rather than proactive.

Title padte hi ek dum se Mahatma Gandhi ki yaad aa gayi. Aaj se KBC ke registration chaalu ho rahe hein

Odisha govt to float a global tender to buy vaccines

Odisha Cabinet headed by CM Naveen Paknaik approved a proposal to float a global tender to procure vaccines for the people of Odisha. This will help Odisha cover vulnerable population thereby saving lives and restoring the livelihoods of people.